Cargando…

Relugolix: A new kid on the block among gonadotrophin-releasing hormone antagonists

Androgen-deprivation therapy (ADT) is the cornerstone of metastatic prostate cancer treatment. ADT can be achieved through surgical castration, or it may be induced either by gonadotrophin-releasing hormone (GnRH) agonists or GnRH antagonists. GnRH antagonists provide a more rapid castration alongsi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fragkoulis, Charalampos, Glykas, Ioannis, Dellis, Athanasios, Mitsogiannis, Iraklis, Papatsoris, Athanasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648026/ https://www.ncbi.nlm.nih.gov/pubmed/34881062 http://dx.doi.org/10.1080/2090598X.2021.1994231

Ejemplares similares

Outcomes of radical cystectomy in pT4 bladder cancer frail patients: Α high-volume single center study
por: Stamatakos, Panagiotis Velissarios, et al.
Publicado: (2022)

Management of stent-related symptoms with the use of α-blockers: A meta-analysis
por: Deliveliotis, Konstantinos, et al.
Publicado: (2019)

Uretero-Ureterostomy Combined With Unilateral Nephrostomy as a Method of Urinary Diversion Following Radical Cystectomy
por: Papadimitriou, Christos, et al.
Publicado: (2022)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Twenty-Four-Month Efficacy of Ureteroureterostomy Combined With Unilateral Nephrostomy Following Radical Cystectomy
por: Papadimitriou, Christos, et al.
Publicado: (2022)

Post Radical Prostatectomy Erectile Dysfunction. A Single Centre Experience
por: Pikramenos, Konstantinos, et al.
Publicado: (2023)

Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders
por: Xia, Min, et al.
Publicado: (2021)

The novel oral gonadotropin‐releasing hormone receptor antagonist relugolix is a new option for controlled ovarian stimulation cycles
por: Komiya, Shinnosuke, et al.
Publicado: (2022)

Novel Optical Technology in Bladder Cancer Diagnosis and Treatment
por: Dellis, Athanasios, et al.
Publicado: (2014)

ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
por: Bamias, Aristotelis, et al.
Publicado: (2021)

Bilateral spontaneous retroperitoneal bleeding in a patient on nimesulide: a case report
por: Mitsogiannis, Iraklis C, et al.
Publicado: (2011)

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy
por: Ito, Mika, et al.
Publicado: (2022)

The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK
por: Rosario, Derek J., et al.
Publicado: (2016)

Bilateral disease and intratesticular haemodynamics as markers of dyspermia in patients with subclinical varicocele: A prospective study
por: Tsampoukas, Georgios, et al.
Publicado: (2019)

Therapeutic effects of an oral gonadotropin‐releasing hormone receptor antagonist, relugolix, on preventing premature ovulation in mild ovarian stimulation for IVF
por: Nakao, Kazuki, et al.
Publicado: (2021)

Why should I do research? Is it a waste of time?
por: Dellis, Athanasios, et al.
Publicado: (2014)

Bilateral Metachronous Testicular Chloroma: A Rare Clinical Entity
por: Dellis, Athanasios, et al.
Publicado: (2013)

Unusual Case of Urethrorectal Fistula in Adolescence in a Patient with a History of Congenital Anorectal Malformation
por: Nastos, Constantinos, et al.
Publicado: (2016)

Profile of Enfortumab Vedotin in the Treatment of Urothelial Carcinoma: The Evidence to Date
por: Moussa, Mohamad, et al.
Publicado: (2021)

Optimizing estradiol level for gonadotrophin-releasing hormone antagonist initiation among patients with simple tubal factor infertility
por: Wang, Yizhuo, et al.
Publicado: (2022)

A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology
por: Hamada, Michiko, et al.
Publicado: (2021)

Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis
por: Dellis, Athanasios, et al.
Publicado: (2017)

The Impact of COVID-19 Disease on Urology Practice
por: Moussa, Mohamad, et al.
Publicado: (2021)

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
por: Osuga, Yutaka, et al.
Publicado: (2021)

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group
por: Pistamaltzian, Nikolaos, et al.
Publicado: (2016)

Expression of proto-oncogene c-Myc in patients with urinary bladder transitional cell carcinoma
por: Fragkoulis, Charalampos, et al.
Publicado: (2021)

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment
por: Lv, Jialu, et al.
Publicado: (2020)

A Randomized Open-Label Study of Relugolix Alone or Relugolix Combination Therapy in Premenopausal Women
por: Lukes, Andrea, et al.
Publicado: (2023)

The effect of gonadotrophin-releasing hormone agonist versus human chorionic gonadotrophin trigger on pregnancy and neonatal outcomes in Letrozole-HMG IUI cycles
por: Chen, Li, et al.
Publicado: (2023)

Using automated imaging to interrogate gonadotrophin-releasing hormone receptor trafficking and function
por: Armstrong, S.P., et al.
Publicado: (2011)

The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization
por: Lee, Kyung-Hee, et al.
Publicado: (2014)

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
por: Dellis, Athanasios, et al.
Publicado: (2021)

Minimal surgical management of penile paraffinoma after subcutaneous penile paraffin injection
por: Dellis, Athanasios E., et al.
Publicado: (2017)

Transcutaneous dorsal penile nerve stimulation for the treatment of premature ejaculation: A novel technique
por: Moussa, Mohamad, et al.
Publicado: (2022)

New kid on the block
Publicado: (2008)

New Kid on the Block
por: Reinheckel, Thomas
Publicado: (2017)

Inguinal lymph node metastasis of bladder carcinoma after radical cystectomy: A case report and review of literature
por: Moussa, Mohamad, et al.
Publicado: (2020)

Atypical small acinar proliferation and its significance in pathological reports in modern urological times
por: Tsampoukas, Georgios, et al.
Publicado: (2022)

Temporal and Spatial Regulation of CRE Recombinase Expression in Gonadotrophin-Releasing Hormone Neurones in the Mouse
por: Wolfe, A, et al.
Publicado: (2008)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_59lmshicka5ij2cpvp18bp8105